aMoon
Overview
aMoon is a global HealthTech and Life Sciences investment fund based in Israel. They partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare, investing across all stages through three investment vehicles: aMoon Velocity, aMoon Growth, and aMoon Edge.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Biosplice Therapeutics | Apr 2021 | VC Round | Co-investor |
| SOPHiA GENETICS | Oct 2020 | Series F | Lead |
| Amylyx Pharmaceuticals | Jul 2021 | Series C | Co-investor |
| Mammoth Biosciences | Jan 2020 | Series B | Co-investor |
| Omada Health, Inc. | Feb 2022 | Series E | Co-investor |
For institutional investors. Book with your work email.
Key People
Marius Nacht
Co-Founder & Anchor Investor
Yair Schindel
Co-Founder Managing Partner
Todd Sone
General Partner
Yaron Daniely
General Partner
Reut Shema
Managing Director
Barak Kariv
Venture Partner Head Of AMoon Insights
Samuel Moed
Venture Partner
Roy Wiesner
Partner
Yael Gruenbaum-Cohen
Partner Head Of AMoon Alpha
Ahuvit David
Principal
Patrick Rivers
Portfolio Manager
Adam Kotzen
Investor
Gaby Hirsch
VP Investor Relations And Communication
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is aMoon based?
aMoon is headquartered in Ra'anana, Central District, Israel.
When was aMoon founded?
aMoon was founded in 2016.
How many portfolio companies does aMoon have?
aMoon has 44 portfolio companies in Caplight's dataset.
What are some companies in aMoon's portfolio?
Portfolio companies visible on Caplight include Biosplice Therapeutics, SOPHiA GENETICS, Amylyx Pharmaceuticals, Mammoth Biosciences, Omada Health, Inc..
What was aMoon's most recent investment shown here?
aMoon's most recent investment in this portfolio sample was in Omada Health, Inc. in 2022.
What sectors does aMoon focus on?
aMoon focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Energy & Sustainability, AI, Data & Cloud Infrastructure, Enterprise Software, FinTech, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Consumer & Commerce, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does aMoon focus on?
aMoon typically invests at the MultiStage stage.
What is aMoon's AUM?
aMoon's assets under management are estimated between $1.0B and $10.0B.